- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30441
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma
Hongli Yan1,3,†,
Yuan Yang2,†,
Ling Zhang1,
Guannan Tang1,
YuZhao Wang1,
Geng Xue1,
Weiping Zhou2 and
Shuhan Sun1,*
DOI: 10.1002/hep.27722
© 2015 by the American Association for the Study of Liver Diseases
Vol. 61 Issue 2
Hepatology
Accepted Article (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)
Author Information
1 Department of Medical Genetics, Second Military Medical University, Shanghai, China
2 The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
3 Department of Laboratory Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, China
† These authors contributed equally to this paper
*Corresponding author. E-mail: [email protected]
ABSTRACT
Early-onset hepatocellular carcinoma (HCC) accounts for 15 to 20% of total HCC cases in Asia, and the incidence is increasing. The low frequency of cirrhosis and poor prognosis of early-onset HCC suggests that its mechanisms may differ from late-onset HCC. Although hepatitis B virus (HBV) infection is epidemiologically associated with HCC, the role of HBV in early-onset HCC remains poorly understood. Here, we report a comparative study on HBV subgenotypes and integration in early- (≤30) and late-onset (≥70) HBV-associated HCC using a novel high-throughput viral integration detection (HIVID) method. We report that HBV B2 is predominantly present in early-onset HCC. HBV integration is a common phenomenon both in early- and late-onset HCC, which favors integrating into human repeat regions. Moreover, we found a breakpoint in 8q24 located between c-Myc and PVT1 which was detected in 12.4% (14/113) of early-onset HCCs, but only 1.4% (2/145) in late-onset HCCs. HBV integrating this site results in c-MYC, PVT1 and miR-1204 over-expression in tumors, thereby potentially contributing to the development of early-onset HCC. Conclusion: To the best of our knowledge, this is the first systematic investigation of HBV genotype and integration in early-onset HCC, and our results may shed light on HCC risk factors in young HBV carriers. Further studies are needed to elucidate at which time in tumor development this integration event occurs and whether it plays an important, causative role in HCC development or progression. This article is protected by copyright. All rights reserved.
|
|